Aciex Inc

Call
Website
82 Flanders Rd Ste 102
Westborough, MA 01581
+1 (508) 436-4940
https://www.nicox.com

Nicox is a global pharmaceutical company headquartered in Valbonne Sophia Antipolis, France, with subsidiaries in the United States and Italy. The company specializes in the research, development, and commercialization of ophthalmic products, with a particular focus on nitric oxide donation technology.

With expertise in chemistry, manufacturing, and clinical development, Nicox is dedicated to advancing therapeutic solutions for various eye diseases, including glaucoma. Through collaborations with contract research organizations and universities worldwide, the company's research institute in Milan manages an extensive patent portfolio and conducts nonclinical development activities.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Vitamin food stores, Real estate managers

Pure Encapsulations

Pure Encapsulations in Sudbury offers a line of premium nutritional supplements that prioritize high-quality, pure ingredients. Backed by verifiable science, their products are free from unnecessary additives and many common allergens, ensuring customers receive the pure difference in every supplement. Generated from their website's infomation
Business services, nec, nec

Geltex Inc

Geltex is a technology company based in Waltham, MA, specializing in software development and data analytics services. With a focus on innovation and efficiency, Geltex provides custom solutions to help businesses streamline their operations and make data-driven decisions. Generated from their business information
Drugs and drug proprietaries

Stoke Therapeutics, Inc

Stoke Therapeutics, Inc., based in Bedford, MA, is pioneering RNA medicine with its proprietary platform, Targeted Augmentation of Nuclear Gene Output (TANGO), aimed at restoring protein expression in diseases caused by gene mutations. The company's focus is primarily on conditions characterized by haploinsufficiencies, including Dravet syndrome and autosomal dominant optic atrophy (ADOA). Stoke's mission is to develop innovative therapies that address the genetic underpinnings of severe diseases, exemplified by their ongoing clinical studies of zorevunersen (STK-001) for Dravet syndrome. Through their commitment to scientific advancement, they aim to improve the lives of patients living with challenges associated with genetic disorders. Generated from the website
United States›Massachusetts›Westborough›Aciex Inc

Partial Data by Infogroup (c) 2025. All rights reserved.